Our Story

Founding of argenx

At a time where access to human antibody engineering technology was difficult, our co-founders found opportunity where scientific discovery met a new approach to innovation. Hear from Tim Hauwermeiren, CEO, and Hans de Haard, Chief Scientific Officer on how argenx grew from an idea to a global immunology company.

Discover Related Stories

Explore more about work to chart a new course in immunology
Our Story
Building Blocks of a Biotech
Our Story
Together We Discover

Interested in Learning More?

Get argenx news and updates right to your inbox


Download assets
Get photos, fact sheets, illustrations and more.
Join the team
Dare to do more with a thriving career at argenx.
Follow us
Get the latest news and info via our social media channels.